<DOC>
	<DOCNO>NCT02458677</DOCNO>
	<brief_summary>This single ascend dose study determine safety , tolerability , pharmacokinetics immunogenicity PRX003 approximately 40 healthy subject .</brief_summary>
	<brief_title>Single Ascending Dose Study PRX003 Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Healthy subject Body mass index ( BMI ) 1832 kg/m2 minimum weight 45 kg Female subject must surgically sterile postmenopausal childbearing potential must use contraception Male subject partner childbearing potential must use contraception Positive test drug abuse Past current history alcohol abuse Positive TB , hepatitis B , hepatitis C HIV infection</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>